Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 20, 2025 • 10:40 AM ET

Date/Time Source News Release
01/10/2025 09:00 AM EST ACCESSWIRE Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
01/08/2025 04:30 PM EST ACCESSWIRE Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
12/18/2024 09:00 AM EST ACCESSWIRE Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
12/17/2024 04:05 PM EST ACCESSWIRE Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
12/16/2024 10:00 AM EST ACCESSWIRE Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
10/30/2024 07:15 AM EDT ACCESSWIRE Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
10/15/2024 10:30 AM EDT ACCESSWIRE Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
09/18/2024 09:00 AM EDT ACCESSWIRE Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
09/17/2024 09:15 AM EDT ACCESSWIRE Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
09/17/2024 09:00 AM EDT ACCESSWIRE Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
Page

Additional News

As of January 20, 2025 • 10:40 AM ET

Date/Time Source News Release
12/17/2024 05:15 PM EST Zacks Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
12/17/2024 04:35 PM EST SeekingAlpha Applied DNA Sciences GAAP EPS of -$0.32 beats by $0.02, revenue of $0.81M misses by $0.09M
12/12/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, December 12th, 2024
12/12/2024 04:30 AM EST US Earnings Reports Expected earnings - Applied DNA Sciences Inc.
12/05/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, December 5th, 2024
12/05/2024 04:30 AM EST US Earnings Reports Expected earnings - Applied DNA Sciences Inc.
11/23/2024 02:48 PM EST SeekingAlpha WHO extends mpox emergency; Canada reports first Clade I case
11/17/2024 01:50 AM EST SeekingAlpha First mpox case linked to African outbreak reported in U.S.
11/13/2024 05:30 PM EST Zacks Intellicheck Mobilisa, Inc. (IDN) Reports Q3 Loss, Misses Revenue Estimates
11/12/2024 07:50 AM EST Zacks GrafTech International (EAF) Reports Q3 Loss, Tops Revenue Estimates
Page